Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study. Here is a roundup of March 2025 U.S. FDA ...